Want to join the conversation?
Anna Kaminskaya of BofA Merrill Lynch asks about $ACM's vertical construction end-market. CEO Michael Burke said $ACM had 25% organic growth in the Building Construction end-market in 2Q16 and it has a robust backlog in this space that will carry through the next few years. A slowdown would not happen for a couple of years.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?